Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Advanced Temperature Controller for Microfluidic Devices for Biotech Research Introduced

By LabMedica International staff writers
Posted on 30 Sep 2014
An innovative temperature controller for use in microfluidic applications is available for use by biotech and other life science researchers.

The microfluidics specialty company Dolomite (Royston, United Kingdom) introduced its new Meros TCU-100 temperature controller at the September 18–19, 2014, Lab-on-a-Chip & Microarray World Congress held in San Diego (CA, USA).

The Meros TCU-100 is the first module in the company's new Meros range of plug-and-play microfluidic products. More...
This line consists of a suite of integrated tools, specifically targeted at microfluidics users in research and education, with the ambition of providing a sophisticated suite of intelligently coordinated capabilities. The suite is be based around a modern touch-screen interface enabling clear visualization of data and virtual reconfiguration of the connected hardware such as pumps and valves. The intuitive and easy to use connections to microfluidic devices is be based on Dolomite’s existing range of microfluidic connectors, Multiflux.

The new Meros TCU-100 temperature controller, which offers advanced temperature control from 1–100 °C, was designed to accommodate a wide range of biological and chemical applications, including cell analysis, thermal control of microreactors, incubation of microdroplets, protein crystallization, nanoparticle synthesis, and thermocycling of micro-scale samples. The instrument is accurate within 0.5 °C with stability and target temperature resolution of 0.1 °C and rapid ramp rates up to 1 °C per second. Operation, data logging, and graphical data display are achieved through Dolomite’s user-friendly Flow Control Center software or third-party software.

“At Dolomite, we believe the scientist should be free to focus on science and not have to worry about finding the right tools for their job. That is why we will provide researchers with a next generation of plug and play microfluidic platforms for use in the laboratory,” said Andrew Lovatt, CEO of Dolomite. “Once again, Dolomite will apply its world-leading expertise in microfluidic solutions to development of innovative technologies.”

Related Links:

Dolomite



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.